| Intrinsic Valuation of: FITBI | |||||||||||
| Free Cash Flow Average and Growth over past 5Y | Key Statistics | ||||||||||
| Year | FCF | FCF (FCF/Revenue) | |||||||||
| 2020 | - | - | EPS (FY) | 3 | Market Cap | $18B | |||||
| 2021 | - | - (-) | P/E Ratio | 7 | Total Asset | $213B | |||||
| 2022 | $2B | - (-) | Net Income | $2B | Total Debt | $14B | |||||
| 2023 | $6B | 139.8% (122.2%) | EBITDA | - | Total Liab | $193B | |||||
| 2024 | $4B | -30.5% (-33.1%) | Opr Margin | - | Debt/Equity | 0.73 | |||||
| 2025 | $2B | -39.6% (-38.4%) | PreTax Margin | - | BV/Share | 16 | |||||
| 5Y Average FCF | $4B | 23.2% (16.9%) | |||||||||
| Overall Market Assumptions: | |||||||||||
| Assumptions: | P/E for No-Growth Company: | 7.0 | |||||||||
| Perpetual Growth Rate (g): | 2.5% | Historical US Bond Yield: | 4.4% | ||||||||
| Discount Rate (WACC): | 7.4% | Current US Bond Yield: | 3.5% | ||||||||
| Forcasting Future Free Cash Flow for next 6Y | Modified Benjamin Graham's Intrinsic Value | ||||||||||
| Year | FCF Projection (23.2%) | ||||||||||
| 2026 | $3B | MBG Intrinsic Value | $31 | ||||||||
| 2027 | $4B | ||||||||||
| 2028 | $5B | ||||||||||
| 2029 | $6B | ||||||||||
| 2030 | $7B | ||||||||||
| 2031 | $8B | ||||||||||
| Terminal Value | $175B | Net Worth/Share | $30 | ||||||||
| DCF Valuation | DCF Valuation "What If" Scenario Table | ||||||||||
| Enterprise Value | $138B | Growth Rate | |||||||||
| (+) Cash & Cash Equivalents | $3B | $193 | 1.5% | 2.0% | 2.5% | 3.0% | 3.5% | ||||
| (-) Total Debt | $14B | WACC | 7.3% | 166 | 181 | 198 | 220 | 247 | |||
| Equity Value | $127B | 7.4% | 164 | 179 | 196 | 217 | 243 | ||||
| Shares Outstanding | 655,616,000 | 7.4% | 163 | 177 | 193 | 214 | 240 | ||||
| 7.9% | 147 | 159 | 172 | 189 | 209 | ||||||
| DCF Intrinsic Value | $193 | 8.4% | 134 | 144 | 155 | 168 | 184 | ||||
| Analyzed by QuantJuice (2025) | |||||||||||